
Top stories






More news



Logistics & Transport
CourierIT expands its delivery network with Same Day and International services







GLP-1 weight-loss injections work. The science says so, and so do the patients who have fought their weight for years and are finally watching it move. Ozempic / Wegovy, Mounjaro and Saxenda are helping people achieve weight loss breakthroughs, that in many cases are life changing.
I spent years in emergency departments and general practice treating the end results of excess weight. Now a medicine exists that works on the brain itself, quietening the appetite signals that genetics and hormones have stacked against some patients their whole lives. The health upside is enormous.
The question is no longer whether they work. It is whether we are using them properly. From what I have seen in South Africa, too often the answer is no.
What I see far too often goes like this. Someone gets a script, collects the medication and starts injecting once a week. Their appetite disappears and the weight falls off. But there is no follow-up on diet, muscle loss or iron and vitamin D levels - or on what happens when the script runs out.
A patient came to see me after she had already lost a lot of weight on a GLP-1. By the scale, it was a success. She was lighter, but she felt horrible. Her blood test results showed that her iron, vitamin D and vitamin B12 were all low, along with other vitamins and minerals. That was why she felt so terrible. She had to go back to the beginning and relearn the basics of eating properly.
That is one patient. Almost half of South African adults are overweight or obese. One of these injections is reportedly already the country’s biggest-selling medicine, and the first generic has just landed, with about a dozen more waiting for approval. Far more people are about to start GLP-1s, and the support for them will likely struggle to keep up with demand.
Many doctors, pharmacies and online platforms have raced to get people onto GLP-1s, without stopping to ask what happens when there is no system around the script. None of the things that I have mentioned are reasons to hold GLP-1s back from people who need them. They are reasons to stop pretending the script is the whole treatment.
When the script is all patients get, three problems come up again and again.
GLP-1s work by turning hunger right down. That is what makes them so effective, but it also creates a problem we have rarely had to manage outside weight-loss surgery. People can eat very little without feeling hungry. With hunger quietened, it is easy to fall short on protein, fibre and other key nutrients without noticing. The result can be a new kind of patient - overweight, but malnourished.
My patient was not unusual. In an analysis of nearly half a million Americans on GLP-1s, one in eight had a recorded nutritional deficiency within six months.
After weight-loss surgery, people also eat far less. That is why their doctors check their bloods and may keep them on vitamin and mineral supplements for years afterwards. Someone on a GLP-1 can end up eating a fraction of what they used to, yet often all they get is a repeat script.
When someone eats this little, every bite counts. Getting enough nutrients out of so little food does not happen by accident. It takes a proper nutrition plan, support and monitoring.
Anyone who loses a lot of weight loses some muscle with it, whether on a diet or on a GLP-1. What is important is the pace of the weight loss, and what surrounds it.
On GLP-1s, people often lose more weight, more quickly, than they ever managed on a diet. In the clinical trials that led to their FDA approval, patients were closely monitored and had regular counselling on diet and exercise.
In the real world, that support is often missing. Without a solid nutrition plan, it is often difficult to eat enough protein. Without an exercise plan, it is easy to skip the strength training that protects muscle. Early data also suggests that patients starting GLP-1s tend to move less than before.
Less food, less protein, less movement, no strength training, and the biggest weight loss of their life. It is the lack of support around the medication, more than the medication itself, that puts muscle at risk.
Most people do not stay on treatment for life. In US data, up to two in three people who start a GLP-1 for weight loss have stopped within a year. Side effects, cost, supply and life all play a part.
When treatment stops, the appetite comes back. In the STEP 1 trial (one of the main trials behind the approval of these medicines for weight loss), people who stopped the medication and the support that came with it, regained about two-thirds of the lost weight within a year. Most of the improvements in blood pressure, blood sugar and cholesterol were lost too.
If someone spends twelve months on a GLP-1 and nothing changes in how they shop, cook, eat, move and sleep, they have only rented a short-term result.
Every script should come with four things from day one: A nutrition plan made for someone on a GLP-1; A plan to maintain muscle; Regular check-ins and blood tests that look at more than the scale; and coaching and support to change the habits underneath, because once the injections stop, habits are what help keep the weight off.
None of this is new. Four major US medical and nutrition societies called for most of it in joint guidance last year. When GLP-1s are prescribed, the script should never go out on its own. If you are on one, make sure yours doesn’t either - many of the problems that I see are preventable.
Using GLP-1s is nothing to be embarrassed about, and it is not “taking the easy way out”. But we should expect more from them than a smaller number on the scale. The aim is simple: that a patient ends up in a genuinely healthier place than where they started - not just lighter.
The prescription is the first step but a script without support is only half the treatment.
Dr Patrick Bennett is a general practitioner with a special interest in obesity and metabolic medicine, and the founder of Flourish, a doctor-led digital obesity-care platform for people on prescription weight-loss medication.
To read more about Flourish, go to https://flourishweightloss.co.za/